(Q37581584)

21 August 2017

1 reference

title

Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression (English)

1 reference

21 August 2017

0 references

Konstantinos A Paschos

series ordinal

1

1 reference

21 August 2017

Stavroula Veletza

series ordinal

2

1 reference

21 August 2017

Ekaterini Chatzaki

series ordinal

3

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

23

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

755-772

1 reference

https://scigraph.springernature.com/pub.10.2165/11310830-000000000-00000

21 August 2017

exact match

0 references

cites work

The stress cascade and schizophrenia: etiology and onset

1 reference

https://api.crossref.org/works/10.2165%2F11310830-000000000-00000

Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11310830-000000000-00000

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11310830-000000000-00000

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11310830-000000000-00000

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11310830-000000000-00000

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

21 January 2018

1 reference

12 December 2020

Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats

1 reference

12 December 2020

A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests

1 reference

12 December 2020

Sigma receptors: biology and function

1 reference

12 December 2020

Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala

1 reference

12 December 2020

Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW 1229U91, on the consumption of highly palatable energy-rich diet

1 reference

12 December 2020

The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test

1 reference

12 December 2020

The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited

1 reference

12 December 2020

Epidemiology of affective disorders: a review

1 reference

12 December 2020

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery.

1 reference

12 December 2020

Some aspects of genetic polymorphism in the biotransformation of antidepressants

1 reference

12 December 2020

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

12 December 2020

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

1 reference

12 December 2020

Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors

1 reference

12 December 2020

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

1 reference

12 December 2020

Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats

1 reference

12 December 2020

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function

1 reference

12 December 2020

Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene

1 reference

12 December 2020

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

1 reference

12 December 2020

The HPA axis in major depression: classical theories and new developments

1 reference

12 December 2020

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

1 reference

12 December 2020

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

1 reference

12 December 2020

Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin

1 reference

12 December 2020

Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant

1 reference

12 December 2020

The corticotropin releasing hormone gene is expressed in human placenta

1 reference

12 December 2020

The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test

1 reference

12 December 2020

Behavioral profiling of NPY in aggression and neuropsychiatric diseases

1 reference

12 December 2020

Neurokinin-1 receptors are decreased in major depressive disorder.

1 reference

12 December 2020

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

1 reference

12 December 2020

Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression

1 reference

12 December 2020

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

1 reference

12 December 2020

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

1 reference

12 December 2020

Demonstration of two distinct tachykinin receptors in rat brain cortex.

1 reference

12 December 2020

Distribution of galanin in the brain of a galanin-overexpressing transgenic mouse

1 reference

12 December 2020

The role of sigma receptors in depression

1 reference

12 December 2020

Maternal experiences of racism and violence as predictors of preterm birth: rationale and study design

1 reference

12 December 2020

The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog

1 reference

12 December 2020

The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.

1 reference

12 December 2020

Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice

1 reference

12 December 2020

A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A--a putative, new antidepressant

1 reference

12 December 2020

Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat

1 reference

12 December 2020

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists

1 reference

12 December 2020

Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?

1 reference

12 December 2020

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

1 reference

12 December 2020

Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension

1 reference

12 December 2020

Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites.

1 reference

12 December 2020

Neurobiology of depression: an integrated view of key findings

1 reference

12 December 2020

Vasopressin antagonists as anxiolytics and antidepressants: recent developments

1 reference

12 December 2020

High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response

1 reference

12 December 2020

Recent advances in the neurobiology of depression.

1 reference

12 December 2020

Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study

1 reference

12 December 2020

Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression

1 reference

12 December 2020

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

12 December 2020

Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices

1 reference

12 December 2020

Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.

1 reference

12 December 2020

Galanin receptor ligands

1 reference

12 December 2020

Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders

1 reference

12 December 2020

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

1 reference

12 December 2020

Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice.

1 reference

12 December 2020

Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects

1 reference

12 December 2020

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

1 reference

12 December 2020

Galanin receptor subtypes

1 reference

12 December 2020

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon

1 reference

12 December 2020

A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor

1 reference

12 December 2020

CRH-like peptides protect cardiac myocytes from lethal ischaemic injury

1 reference

12 December 2020

Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.

1 reference

12 December 2020

NK-3 receptors are expressed on mouse striatal gamma-aminobutyric acid-ergic interneurones and evoke [(3)H] gamma-aminobutyric acid release

1 reference

12 December 2020

Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils

1 reference

12 December 2020

The neurobiology of depression: inroads to treatment and new drug discovery

1 reference

12 December 2020

Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor

1 reference

12 December 2020

History and evolution of the monoamine hypothesis of depression.

1 reference

12 December 2020

Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects

1 reference

12 December 2020

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.

1 reference

12 December 2020

New insights into the antidepressant actions of substance P (NK1 receptor) antagonists

1 reference

12 December 2020

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

1 reference

12 December 2020

Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress

1 reference

12 December 2020

Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries

1 reference

12 December 2020

Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors

1 reference

12 December 2020

Binding properties of SA4503, a novel and selective sigma 1 receptor agonist

1 reference

12 December 2020

Galanin receptor subtypes

1 reference

12 December 2020

Involvement of vasopressin in affective disorders

1 reference

12 December 2020

Elevated CSF CRF in suicide victims

1 reference

12 December 2020

Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523.

1 reference

12 December 2020

Plasma levels of arginine vasopressin elevated in patients with major depression.

1 reference

12 December 2020

Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report.

1 reference

12 December 2020

Early adverse experience as a developmental risk factor for later psychopathology: Evidence from rodent and primate models

1 reference

12 December 2020

Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat.

1 reference

12 December 2020

Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis

1 reference

12 December 2020

Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.

1 reference

12 December 2020

Vasopressin and oxytocin localization and putative functions in the brain

1 reference

12 December 2020

Mechanism of action of antidepressants and therapeutic perspectives

1 reference

12 December 2020

Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test

1 reference

12 December 2020

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

12 December 2020

Effect of combined treatment with selective sigma ligands and amantadine in the forced swimming test in rats

1 reference

12 December 2020

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

1 reference

12 December 2020

NPY and Y receptors: lessons from transgenic and knockout models

1 reference

12 December 2020

Galanin and its receptors in neurological disorders

1 reference

12 December 2020

Galanin immunoreactivity in the primate central nervous system

1 reference

12 December 2020

Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.

1 reference

12 December 2020

Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests

1 reference

12 December 2020

The central vasopressinergic system: examining the opportunities for psychiatric drug development

1 reference

12 December 2020

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

12 December 2020

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

12 December 2020

Galanin: a significant role in depression?

1 reference

12 December 2020

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

12 December 2020

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.

1 reference

12 December 2020

5-Hydroxytryptamine-induced outward currents mediated via 5-HT(1A) receptors in neurons of the rat dorsolateral septal nucleus

1 reference

12 December 2020

Hippocampal volume reduction and HPA-system activity in major depression

1 reference

12 December 2020

Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors.

1 reference

12 December 2020

Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression

1 reference

12 December 2020

Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo

1 reference

12 December 2020

Cerebrospinal fluid vasopressin in neurological and psychiatric disorders

1 reference

12 December 2020

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor

1 reference

12 December 2020

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.

1 reference

12 December 2020

Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze

1 reference

12 December 2020

Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature

1 reference

12 December 2020

Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

1 reference

12 December 2020

Effects of three galanin analogs on the outward current evoked by galanin in locus coeruleus.

1 reference

12 December 2020

Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes

1 reference

12 December 2020

Anxious-retarded depression: relation with plasma vasopressin and cortisol

1 reference

12 December 2020

Characterization of the binding of [125I-iodo-histidyl, methyl-Phe7] neurokinin B to the neurokinin-3 receptor.

1 reference

12 December 2020

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

12 December 2020

Receptors and antagonists for substance P and related peptides

1 reference

12 December 2020

Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls

1 reference

12 December 2020

Corticotropin-Releasing Factor Receptor-2-Deficient Mice Display Abnormal Homeostatic Responses to Challenges of Increased Dietary Fat and Cold

1 reference

12 December 2020

Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions

1 reference

12 December 2020

The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium

1 reference

12 December 2020

A proposal for the classification of sigma binding sites

1 reference

12 December 2020

Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors

1 reference

12 December 2020

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo

1 reference

12 December 2020

Neurobiology of posttraumatic stress disorder.

1 reference

12 December 2020

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

1 reference

12 December 2020

Neuropeptides, dopamine, and schizophrenia

1 reference

12 December 2020

Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents

1 reference

12 December 2020

Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice

1 reference

12 December 2020

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

1 reference

12 December 2020

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

1 reference

12 December 2020

Tachykinin NK(3)receptor involvement in anxiety.

1 reference

12 December 2020

Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease

1 reference

12 December 2020

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

1 reference

12 December 2020

Stress and the brain: from adaptation to disease

1 reference

12 December 2020

The role of substance P in stress and anxiety responses

1 reference

12 December 2020

Modelling a loss event: effect of imagined bereavement on the hypothalamic-pituitary-adrenal axis.

1 reference

12 December 2020

XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors

1 reference

12 December 2020

Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994

1 reference

12 December 2020

Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.

1 reference

12 December 2020

Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain

1 reference

12 December 2020

Galanin, galanin receptor subtypes and depression-like behaviour

1 reference

12 December 2020

3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.

1 reference

12 December 2020

Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole

1 reference

12 December 2020

Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.

1 reference

12 December 2020

Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results

1 reference

12 December 2020

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

12 December 2020

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

12 December 2020

Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study

1 reference

12 December 2020

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

1 reference

12 December 2020

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

1 reference

12 December 2020

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression

1 reference

12 December 2020

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

1 reference

12 December 2020

Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I.

1 reference

12 December 2020

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

1 reference

12 December 2020

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

1 reference

12 December 2020

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

1 reference

12 December 2020

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

1 reference

12 December 2020

Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels

1 reference

12 December 2020

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

1 reference

12 December 2020

Circulating human corticotropin-releasing factor-binding protein levels following cortisol infusions

1 reference

12 December 2020

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

1 reference

12 December 2020

Distribution of galaninergic immunoreactivity in the brain of the mouse.

1 reference

12 December 2020

Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2).

1 reference

12 December 2020

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.

1 reference

12 December 2020

CRH-sub-1 receptor antagonists for the treatment of depression and anxiety

1 reference

12 December 2020

Pharmacological evidence supporting a role for galanin in cognition and affect

1 reference

12 December 2020

Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments

1 reference

12 December 2020

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests

1 reference

12 December 2020

The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats

1 reference

12 December 2020

Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice

1 reference

12 December 2020

Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study

1 reference

12 December 2020

Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism

1 reference

12 December 2020

Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala

1 reference

12 December 2020

Major Depressive Disorder

1 reference

12 December 2020

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

1 reference

12 December 2020

Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

1 reference

12 December 2020

Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior

1 reference

12 December 2020

Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression

1 reference

12 December 2020

Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.

1 reference

12 December 2020

Clinical trials with sigma ligands

1 reference

12 December 2020

CRF receptor antagonists: utility in research and clinical practice

1 reference

12 December 2020

Vasopressin and oxytocin receptors

1 reference

12 December 2020

Neuropeptide Y (NPY) and depression: from animal studies to the human condition

1 reference

12 December 2020

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.

1 reference

12 December 2020

Treatment-resistant depression: managed care considerations.

1 reference

12 December 2020

10.2165/11310830-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1043815508

0 references

1 reference